ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,732,000 | -17.0% | 441,649 | -4.9% | 3.89% | -42.3% |
| Q4 2018 | $21,374,000 | -59.9% | 464,649 | -61.3% | 6.74% | -52.6% |
| Q3 2018 | $53,248,000 | +13.2% | 1,200,100 | 0.0% | 14.21% | +86.0% |
| Q2 2018 | $47,032,000 | +288.0% | 1,200,100 | +616.1% | 7.64% | +55.3% |
| Q1 2018 | $12,121,000 | -16.3% | 167,587 | -42.0% | 4.92% | -42.0% |
| Q4 2017 | $14,490,000 | 0.0% | 289,100 | 0.0% | 8.49% | +12.7% |
| Q3 2017 | $14,490,000 | -7.9% | 289,100 | -15.0% | 7.53% | -24.1% |
| Q2 2017 | $15,740,000 | +31.1% | 340,100 | 0.0% | 9.92% | +77.2% |
| Q1 2017 | $12,009,000 | – | 340,100 | – | 5.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |